409 related articles for article (PubMed ID: 18294274)
1. Production and characterization of highly tumor-specific rat monoclonal antibodies recognizing the extracellular domain of human L-type amino-acid transporter 1.
Ohno Y; Suda K; Masuko K; Yagi H; Hashimoto Y; Masuko T
Cancer Sci; 2008 May; 99(5):1000-7. PubMed ID: 18294274
[TBL] [Abstract][Full Text] [Related]
2. Oncogenicity of L-type amino-acid transporter 1 (LAT1) revealed by targeted gene disruption in chicken DT40 cells: LAT1 is a promising molecular target for human cancer therapy.
Ohkawa M; Ohno Y; Masuko K; Takeuchi A; Suda K; Kubo A; Kawahara R; Okazaki S; Tanaka T; Saya H; Seki M; Enomoto T; Yagi H; Hashimoto Y; Masuko T
Biochem Biophys Res Commun; 2011 Mar; 406(4):649-55. PubMed ID: 21371427
[TBL] [Abstract][Full Text] [Related]
3. Expression of LAT1 and LAT2 amino acid transporters in human and rat intestinal epithelial cells.
Fraga S; Pinho MJ; Soares-da-Silva P
Amino Acids; 2005 Nov; 29(3):229-33. PubMed ID: 16027961
[TBL] [Abstract][Full Text] [Related]
4. Towards therapeutic antibodies to membrane oncoproteins by a robust strategy using rats immunized with transfectants expressing target molecules fused to green fluorescent protein.
Masuko T; Ohno Y; Masuko K; Yagi H; Uejima S; Takechi M; Hashimoto Y
Cancer Sci; 2011 Jan; 102(1):25-35. PubMed ID: 21040216
[TBL] [Abstract][Full Text] [Related]
5. System L-amino acid transporters are differently expressed in rat astrocyte and C6 glioma cells.
Kim DK; Kim IJ; Hwang S; Kook JH; Lee MC; Shin BA; Bae CS; Yoon JH; Ahn SG; Kim SA; Kanai Y; Endou H; Kim JK
Neurosci Res; 2004 Dec; 50(4):437-46. PubMed ID: 15567481
[TBL] [Abstract][Full Text] [Related]
6. Genetic polymorphisms in the amino acid transporters LAT1 and LAT2 in relation to the pharmacokinetics and side effects of melphalan.
Kühne A; Kaiser R; Schirmer M; Heider U; Muhlke S; Niere W; Overbeck T; Hohloch K; Trümper L; Sezer O; Brockmöller J
Pharmacogenet Genomics; 2007 Jul; 17(7):505-17. PubMed ID: 17558306
[TBL] [Abstract][Full Text] [Related]
7. Enhanced tumor growth elicited by L-type amino acid transporter 1 in human malignant glioma cells.
Kobayashi K; Ohnishi A; Promsuk J; Shimizu S; Kanai Y; Shiokawa Y; Nagane M
Neurosurgery; 2008 Feb; 62(2):493-503; discussion 503-4. PubMed ID: 18382329
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetic role of L-type amino acid transporters LAT1 and LAT2.
del Amo EM; Urtti A; Yliperttula M
Eur J Pharm Sci; 2008 Oct; 35(3):161-74. PubMed ID: 18656534
[TBL] [Abstract][Full Text] [Related]
9. Anti-tumor effects of mAb against L-type amino acid transporter 1 (LAT1) bound to human and monkey LAT1 with dual avidity modes.
Ueda S; Hayashi H; Miyamoto T; Abe S; Hirai K; Matsukura K; Yagi H; Hara Y; Yoshida K; Okazaki S; Tamura M; Abe Y; Agatsuma T; Niwa SI; Masuko K; Masuko T
Cancer Sci; 2019 Feb; 110(2):674-685. PubMed ID: 30548114
[TBL] [Abstract][Full Text] [Related]
10. Enhanced tumorigenicity caused by truncation of the extracellular domain of GP125/CD98 heavy chain.
Hara K; Kudoh H; Enomoto T; Hashimoto Y; Masuko T
Oncogene; 2000 Dec; 19(54):6209-15. PubMed ID: 11175335
[TBL] [Abstract][Full Text] [Related]
11. L-type amino acid transporters LAT1 and LAT4 in cancer: uptake of 3-O-methyl-6-18F-fluoro-L-dopa in human adenocarcinoma and squamous cell carcinoma in vitro and in vivo.
Haase C; Bergmann R; Fuechtner F; Hoepping A; Pietzsch J
J Nucl Med; 2007 Dec; 48(12):2063-71. PubMed ID: 18056335
[TBL] [Abstract][Full Text] [Related]
12. l-type amino acid transporter 1 and CD98 expression in primary and metastatic sites of human neoplasms.
Kaira K; Oriuchi N; Imai H; Shimizu K; Yanagitani N; Sunaga N; Hisada T; Tanaka S; Ishizuka T; Kanai Y; Endou H; Nakajima T; Mori M
Cancer Sci; 2008 Dec; 99(12):2380-6. PubMed ID: 19018776
[TBL] [Abstract][Full Text] [Related]
13. Expression of L-type amino acid transporter 1 in a rat model of liver metastasis: positive correlation with tumor size.
Tamai S; Masuda H; Ishii Y; Suzuki S; Kanai Y; Endou H
Cancer Detect Prev; 2001; 25(5):439-45. PubMed ID: 11718450
[TBL] [Abstract][Full Text] [Related]
14. L-type amino acid transporter 1-mediated L-leucine transport at the inner blood-retinal barrier.
Tomi M; Mori M; Tachikawa M; Katayama K; Terasaki T; Hosoya K
Invest Ophthalmol Vis Sci; 2005 Jul; 46(7):2522-30. PubMed ID: 15980244
[TBL] [Abstract][Full Text] [Related]
15. Prognostic significance of L-type amino acid transporter 1 (LAT1) and 4F2 heavy chain (CD98) expression in stage I pulmonary adenocarcinoma.
Kaira K; Oriuchi N; Imai H; Shimizu K; Yanagitani N; Sunaga N; Hisada T; Ishizuka T; Kanai Y; Nakajima T; Mori M
Lung Cancer; 2009 Oct; 66(1):120-6. PubMed ID: 19171406
[TBL] [Abstract][Full Text] [Related]
16. Expression and functional characterization of the system L amino acid transporter in KB human oral epidermoid carcinoma cells.
Yoon JH; Kim YB; Kim MS; Park JC; Kook JK; Jung HM; Kim SG; Yoo H; Ko YM; Lee SH; Kim BY; Chun HS; Kanai Y; Endou H; Kim DK
Cancer Lett; 2004 Mar; 205(2):215-26. PubMed ID: 15036654
[TBL] [Abstract][Full Text] [Related]
17. Lysophosphatidylcholine enhances cytokine production of endothelial cells via induction of L-type amino acid transporter 1 and cell surface antigen 4F2.
Takabe W; Kanai Y; Chairoungdua A; Shibata N; Toi S; Kobayashi M; Kodama T; Noguchi N
Arterioscler Thromb Vasc Biol; 2004 Sep; 24(9):1640-5. PubMed ID: 15178563
[TBL] [Abstract][Full Text] [Related]
18. A panel of monoclonal antibodies recognizing GPI-anchored ADP-ribosyltransferase ART4, the carrier of the Dombrock blood group antigens.
Parusel I; Kahl S; Braasch F; Glowacki G; Halverson GR; Reid ME; Schawalder A; Ortolan E; Funaro A; Malavasi F; Hardie D; Halder S; Buckley CD; Haag F; Koch-Nolte F
Cell Immunol; 2005; 236(1-2):59-65. PubMed ID: 16168396
[TBL] [Abstract][Full Text] [Related]
19. Impact of system L amino acid transporter 1 (LAT1) on proliferation of human ovarian cancer cells: a possible target for combination therapy with anti-proliferative aminopeptidase inhibitors.
Fan X; Ross DD; Arakawa H; Ganapathy V; Tamai I; Nakanishi T
Biochem Pharmacol; 2010 Sep; 80(6):811-8. PubMed ID: 20510678
[TBL] [Abstract][Full Text] [Related]
20. Production of monoclonal antibodies using spleen cells from nude mice bearing human tumors.
Al Saati T; Blancher A; Calvas P; Neulat-Duga I; Delsol G
Ann Pathol; 1987; 7(1):1-8. PubMed ID: 3040026
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
